- Case report
- Open Access
- Open Peer Review
Benign chondroid syringoma of the orbit: a rare cause of exophtalmos
© Belfquih et al; licensee BioMed Central Ltd. 2012
- Received: 10 January 2012
- Accepted: 8 March 2012
- Published: 8 March 2012
Chondroid syringoma (CS) of the orbit is an extremely rare benign neoplasm. To the best of our knowledege, this is the second case reported in the english litérature.
We report a case of a 41-year-old woman with orbital CS. This tumor developed slowly over 8 years causing indolor, no axil, exophtalmos of the left eye. Computed tomography demonstrated an isodense intraorbital tumor with homogeneous enhancement without bony erosion. On Magnetic resonance imaging the tumor was isointense on T1-weighted imaging, slightly hyper intense on T2-weighted imaging, and enhanced after Gadolinium administration. The patient was operated via left lateral orbitotomy. At surgery the mass was well circumscribed, extraconal, very firm and did not invade or adhere to other structures. The tumor was removed in toto. The diagnosis was confirmed by histopathological examination, the lesion was nodular, and there was differentiation toward the adnexal ductal epithelium with chondromyxoid and adipocytic differentiation in the stroma. No recurrence was seen with one year follow-up.
CS should be included in the differential diagnosis of intra-orbital tumors. Complete resection remains the best therapeutic option to prevent recurrence. Close followup is recommended because malignant transformation, although rare, is possible.
- Chondroid syringoma
- Intraorbital tumor
- Lateral orbitotomy
Chondroid syringoma (CS) are rare mixed tumours of sweat-gland which were first described by Billroth in 1859, that have both a bening and malignant form. Hirsch and Helwig in 1961  gave them the appellation CS, because of the presence of sweat gland elements which are set in a cartilaginous stroma. The commonest sites are the scalp, cheek, nose, upper lip, chin, and the forehead.
CS of the orbit are extremely rare. In the better of our knowledege, only one case has been reported in the english litérature . Here we report an unusual case of a patient who underwent complete resection of a intraorbital CS. The clinical presentation, histologycal findings and treatment, with review of the relevant literature, are discussed.
Chondroid syringoma (CS) is a rare, benign, skin appendagal tumor, first described by Billorth in 1859 for a group of tumors of the salivary gland that contained varying amounts of mucoid and cartilaginous material . Virchow and Minssen referred to them as mixed tumors with both epithelial and mesenchymal origin . The term « chondroid syringoma » was coined by Hirsh and Helwig (1961) to refer to a type of skin tumour originating in the apocrine sweat glands, comprised of glandular elements and stroma, similar to cartilage (mixed cutaneous tumour). They also proposed five histopathological criteria for its diagnosis: 1) nests of cuboidal or polygonal cells; 2) intercommunicating tubuloalveolar structures lined with two or more rows of cuboidal cells; 3) ductal structures composed of one or two rows of cuboidal cells; 4) occasional keratinous cysts; 5) a matrix of varying composition. Chondroid syringomas may have all five characteristics or manifest only some .four criterias were found in our case.
Clinically, CS presents typically as a slow growing, painless, firm, non-ulcerated subcutaneous or intracutaneous nodule. The lesion commonly measures 0.5-3 cm in diameter . However, larger forms of CS have been described .
The sites of predilection for CS are on the head and neck region, particularly cheek, nose, or skin above the lip [3, 5]. Less commonly, this tumor can develop on the scalp, eyelid, hand, foot, forehead, axillary region, abdomen, penis, vulva, and scrotum [6–8].orbital location is exceptional. A medline database was questioned using the key words: CS-orbit, only one case can be found .
Kitazawa T and al  have reported in 1999 the first case of a woman complaining of left exophtalmos and diplopia, a firm mass was palpable in the left lateral canthal region, CT and MRI demonstrated a extraconal mass extending to the malar subcutis and associated with compression of the globe, the tumor was resected easily and the diagnosis of benign chondroid syringoma was confirmed by histopathological examination. No mass palpable was found in our case.
Histologically, CS consists of mixed epithelial and mesenchymal elements, with epithelial cells arranged in cords and forming tubules with a myoepithelial layer, set in a myxoid or chondroid stroma [4, 9]. Osteoid stroma or mature adipocytes can be present in rare cases . Two histological variants of this tumor are described, the eccrine type with smaller lumens lined by a single row of cuboidal epithelial cells and the apocrine variant with tubular and cystic branching lumina lined by two rows of epithelial cells . Immunohistochemical study shows focal positivity for keratin, vimentin, desmin, and S-100 protein in the stroma .
Radiological features of CS are not as suggestive as the histological findings. The MRI features are non-specific, but can accurately depict the anatomic extent and identify tissue of origin, depth of invasion and relation to adjacent structures, such as muscles and bones .
The differential diagnosis of CS is made with other benign orbital lesions include pleomorphic adenoma, dermoids, lipomas, neurofibromas, meningioma, lymphangiomas, Cavernous hemangiomas and histiocytic tumors. . We describe our patient to point out that this tumor should be considered a rare possibility in the differential diagnosis of orbital tumors. CS lesions usually are not clinically or radiology distinctive and the diagnosis is made on histological examination [3, 4].
The treatment of choice is complete excision without esthetic or functional disruption of surrounding structures . Lateral orbitotomy is a safe approach in the surgical management of lesions in the lateral orbital region, particularly if the lesions are extraconal . It has been suggested that incisional biopsy or fine-needle aspiration may disrupt the tumor and seed local tissue, increasing the risk of recurrence. In our observation, the tumor was completely excised without recurrence within a 1-year followup.
Chondroid syringoma is a benign tumor. However, rare cases of malignant CS have been reported [3, 13]. These malignant forms occur more commonly in younger female patients, and have a predilection for occurring on the trunk or extremities [3, 13]. These tumors often are larger than 3 cm and are locally invasive. Histological findings such as cytologic atypia, infiltrative margins, satellite tumor nodules, tumor necrosis, and involvement of deep structures are considered as signs of malignant transformation [4, 14]. Close follow-up of these tumors is recommended because of risk of malignancy and recurrence.
Chondroid syringoma should be included in the differential diagnosis of intraorbital tumors, especially in middle-aged patients. Although malignant forms and recurrence are extremely rare, wide excision of the tumor and long-term followup are the most effective ways of management.
Written informed consent was obtained from the patient for publication of this Case report and any accompanying images.
- Hirsch P, Helwig EB: Chondroid syringoma: mixed tumour of the skin, salivary gland type. Arch Dermatol. 1961, 84: 835-847. 10.1001/archderm.1961.01580170129018.View ArticlePubMedGoogle Scholar
- Kitazawa T, Hataya Y, Matsuo K: Chondroid syringoma of the orbit. Ann Plast Surg. 1999, 42 (1): 100-102. 10.1097/00000637-199901000-00018.View ArticlePubMedGoogle Scholar
- Sungur N, Uysal A, Gümüs M, Kocer U: An unusual chondroid syringoma. Dermatol Surg. 2003, 29: 977-979. 10.1046/j.1524-4725.2003.29264.x.PubMedGoogle Scholar
- Yavuzer R, Basterzi Y, Sari A, Bir F, Sezer C: Chondroid syringoma: A diagnosis more frequent than expected. Dermatol Surg. 2003, 29: 179-181. 10.1046/j.1524-4725.2003.29045.x.PubMedGoogle Scholar
- Bekerecioglu M, Tercan M, Karakok M, Atik B: Benign chondroid syringoma: a confusing clinical diagnosis. Eur J Plast Surg. 2002, 25: 316-318. 10.1007/s00238-002-0385-5.View ArticleGoogle Scholar
- Poku JW, Sant GR, Ucci AA: Chondroid syringoma of the scrotum. J Int Med Res. 1996, 24: 482-486.PubMedGoogle Scholar
- Nemoto K, Kato N, Arino H: Chondroid syringoma of the hand. Scand J Plast Reconstr Surg Hand Surg. 2002, 36: 379-381. 10.1080/028443102321096401.View ArticlePubMedGoogle Scholar
- Takamitsu O, Shinichi W: Histogenesis of mixed tumor of the skin, apocrine type: immunohistochemical study of keratin expression. Am J of Dermatopathol. 1997, 19: 456-461. 10.1097/00000372-199710000-00004.View ArticleGoogle Scholar
- Miracco C, De Santi MM, Lalinga AV: Lipomatous mixed tumour of the skin: a histological, immunohistochemical and ultrastructural study. Br J of Dermatol. 2002, 146: 899-903. 10.1046/j.1365-2133.2002.04645.x.View ArticleGoogle Scholar
- Nicolaou S, Dubec JJ, Munk PL, O'Connell JX, Lee MJ: Malignant chondroid syringoma of the skin: magnetic resonance imaging features. Australas Radiol. 2001, 45: 240-243. 10.1046/j.1440-1673.2001.00912.x.View ArticlePubMedGoogle Scholar
- Goldberg SH, Cantore WA: Tumors of the orbit. Curr Opin Ophthalmol. 1997, 8 (5): 51-56. 10.1097/00055735-199710000-00011.View ArticlePubMedGoogle Scholar
- Arai H, Sato K, Katsuta T, Rhoton A: Lateral approach to intraorbital lesions: Anatomic and surgical considerations. Neurosurgery. 1996, 39: 1157-1163. 10.1097/00006123-199612000-00018.View ArticlePubMedGoogle Scholar
- Barnett MD, Wallack MK, Zuretti A, Mesia L, Emery RS, Berson AM: Recurrent malignant chondroid syringoma of the foot: a case report and review of the literature. Am J Oncol. 2000, 23: 227-232. 10.1097/00000421-200006000-00003.View ArticleGoogle Scholar
- Bates AW, Baithun SI: Atypical Mixed Tumor of the Skin: histologic, immunohistochemical, and ultrastructural features in three cases and a review of the criteria for malignancy. Am J of Dermatopathol. 1998, 20: 35-40. 10.1097/00000372-199802000-00007.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.